Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Neoplasm Metastasis × Everolimus × Clear all

Phase

Phase 2 14 Phase 1 13 Phase NA 3 Phase 3 3 Phase 1/2 3 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 5 Neoplasms 3 Tuberous Sclerosis 2 Neuroendocrine Tumors 2 Kidney Neoplasms 2 Breast Neoplasms 2 Angiomyolipoma 2 Waldenstrom Macroglobulinemia 1 Skin Neoplasms 1 Skin Diseases 1 Pancreatic Neuroendocrine Tumors 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Lymphoma 1 Lymphangioleiomyomatosis 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Carcinoid Tumor 1 Breast Diseases 1

Interventions

Zoledronic Acid 3 Bevacizumab 3 exemestane 2 Therapeutics 2 Oxaliplatin 2 Misoprostol 2 Magnetic Resonance Spectroscopy 2 Letrozole 2 Ibandronic Acid 2 Fluorouracil 2 Cetuximab 2 Capecitabine 2 vandetanib 1 palbociclib 1 liposomal doxorubicin 1 huaier 1 eribulin 1 enzalutamide 1 darolutamide 1 cabozantinib 1 aldesleukin 1 Vindesine 1 Trastuzumab 1 Sugars 1 Stents 1 Standard of Care 1 Sorafenib 1 Radiosurgery 1 Platinum 1 Pharmaceutical Preparations 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02248571 2017-11-13

IMPROVE

iOMEDICO AG

Phase 4 Completed

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡